The government on Monday said it identified 26 potential cases of bleeding and blood clotting in India due to the administration of the AstraZeneca vaccine in India. As per a report submitted by the National AEFI (Adverse Event Following Immunization) Committee to the Ministry of Health & Family Welfare, "more than 23,000 adverse events were reported" through the CO-WIN platform reported from 684 of the 753 districts of the country.from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3yeKpBX
0 Comments